Patents
-
Patent Number Year Symeres Authors Customer HIV Replication Inhibiting Purine Derivatives WO 2005028479 2005 Ruben Leenders, Dirk Vandenput Janssen Pharma-ceutica N.V. (CMD) -
Patent Number Year Symeres Authors Customer Processes for the Preparation of 4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile WO 2004016581 2004 Ruben Leenders Janssen Pharma-ceutica N.V. (CMD) -
Patent Number Year Symeres Authors Customer N-Phenyl-(4-pyridyl)-Azinylamine Derivatives as Plant Protection Agents WO 2004/084634 2004 Ruud Titulaer Syngenta -
Patent Number Year Symeres Authors Customer Method of preparation of a precursor oligocene WO 2004083160 A1 20040930 2004 Wolter ten Hoeve Philips -
Patent Number Year Symeres Authors Customer HIV Inhibiting 1,2,4-Triazines WO 2004074266 2004 Ruben Leenders Janssen Pharma-ceutica N.V. (CMD) -
Patent Number Year Symeres Authors Customer Novel Process WO 2022/167817 A1 2022 Mark Verhaar Artios Pharma -
Patent Number Year Symeres Authors Customer Novel processes for the preparation or (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol US20020151717 2002 Jan Koek Aventis Pharmaceuticals Inc. -
Patent Number Year Symeres Authors Customer HIV Replication Inhibitors US 20030171374 2003 Ruben Leenders Janssen Pharma-ceutica N.V. (CMD) -
Patent Number Year Symeres Authors Customer Enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1H-quinolin-2-one and salts thereof, useful in the treatment of cancer US7176315 B2 2002 Kees Pouwer Pfizer Inc. -
Patent Number Year Symeres Authors Customer Method for the preparation of enantiomerically enriched compounds WO 0142173 2000 Jean-Paul Seerden, Marcel van der Sluis DSM
Feel free to contact us!
Curious to know more about what can we do for you? Get in touch and let’s start a conversation.
